Mary Kay co-sponsors leading world skin science conference

Beauty and personal care giant Mary Kay has announced it will sponsor an exclusive symposium at the International Investigative Dermatology(IID) Meeting to be held in Orlando in Florida in mid-2018.

Organized jointly every five years by the world’s pre-eminent skin health research organizations from Europe (the European Society for Dermatological Research), Asia (the Japanese Society for Investigative Dermatology) and North America (the Society of Investigative Dermatology), the International Investigative Dermatology Meeting brings together the world’s finest researchers in the fields of cutaneous biology and related disciplines.

“Helping advance the knowledge of the effects of pollution on skin health, and discovering new perspectives and intervention strategies demonstrates Mary Kay’s commitment to skin science,” says Dr. Lucy Gildea, Mary Kay’s Chief Scientific Officer.

“Our sponsorship of IID is a remarkable opportunity for Mary Kay to exchange ideas and findings with our colleagues in industry and academia regarding pollution and skin health,” she added.

Sponsoring the International Investigative Dermatology Meeting is just the latest showcase among a series of Mary Kay partnerships with the scientific and academic communities.

Mary Kay has always committed to the support for research grants and projects with the University Texas Southwest Medical Center in both skin care and women’s health. Mary Kay has also partnered with the American Academy of Dermatology and the Society of Cosmetic Chemists.

Responding to the rising concern of pollution and declining air quality around the world, Mary Kay’s most recent research initiative has been focusing on the harmful effects of air pollution, UV radiation and other environmental stressors on the skin.

Mary Kay invests millions of dollars annually in skin health research and development, consolidating its position as one of the world’s leading cosmetic industry innovators.

The recent appointment of Lucy Gildea, who holds a Ph.D degree in cell and molecular biology, as Chief Scientific Officer and the groundbreaking of a US$125 million dollar state-of-the-art manufacturing and R&D facility in Lewisville, Texas, further extend Mary Kay’s leadership in science-based product development and innovation.

Each year, Mary Kay conducts hundreds of thousands scientific tests on its latest skin care innovations to ensure the highest standards of safety, quality and performance.

It has also set a company milestone with more than 1,400 patents for products, technologies and packaging designs in its global portfolio.